Tweet
Financial Express |
Glaxo to start clinical trials for Ebola vaccine The Hill British drug maker GlaxoSmithKline will start clinically testing an Ebola vaccine as international health observers struggle to contain a outbreak of the deadly disease. Glaxo will partner with the National Institutes of Health to start a Phase I trial, giving the ... Ebola Vaccine Trials Set to Begin in SeptemberU.S. News & World Report Clinical trial to start soon on GSK Ebola vaccineReuters US emergency labs ready to work on Ebola drugsNews24 FierceBiotech -Bidness Etc all 149 news articles » |
More...